ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Amgen’s New Products Deliver Double-Digit Growth While Facing Down Pricing Pressure for New Migraine Drug
biospace
April 26, 2018In its first-quarter earnings?report,?Thousand Oaks, California-based?Amgen?cited total revenue for the quarter of $5.6 billion, up 2 percent compared to the first quarter of 2017. -
Amgen's Migraine Drug Heads Toward Possible May Approval
biospace
April 19, 2018Amgen?announced?final data from its Phase IIIb LIBERTY clinical trial of Aimovig (erenumab), with positive results likely to lead to a blockbuster drug for migraine sufferers. -
Amgen Jumps as Migraine Drug Wows in Late-Stage Study
biospace
January 24, 2018Amgen’s migraine drug Aimovig continues to impress with its efficacy in late-stage studies. -
Novartis files migraine drug with EMA
pharmaphorum
June 22, 2017Novartis has filed its migraine drug erenumab with the EMA, putting it in pole position among a group of pharma companies racing to develop a new class of drugs to treat the debilitating condition.
Pharma Sources Insight January 2025
